Loading...
Chemical structure of MIDD0301

GC70552

MIDD0301

Also known as (4R)-8-bromo-6-(2-fluorophenyl)-4-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

MIDD0301 (GL-II-93) is an orally effective, anti-asthmatic positive allosteric modulator of GABAA receptor

ChemicalCAS2187489-08-1MW414.23FormulaC19H13BrFN3O2
CAS number
2187489-08-1
Molecular weight
414.23
Formula
C19H13BrFN3O2
Solubility
DMSO ： 100 mg/mL (241·41 mM; ultrasonic and warming and heat to 80°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
OSBXEAZWQGBYFU-SNVBAGLBSA-N
Catalogue number
GC70552
Brand
GLPBIO
Computed properties PubChem CID 133081966 · XLogP 3.8 · TPSA 67.5 Ų · H-bond donors 1
XLogP
3.8
TPSA
67.5 Ų
H-bond donors
1
H-bond acceptors
5
Rotatable bonds
2
Heavy atoms
26

SMILES C[C@@H]1C2=C(N=CN2C3=C(C=C(C=C3)Br)C(=N1)C4=CC=CC=C4F)C(=O)O

Computed descriptors from PubChem (CID 133081966), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.